PubMed

Trials that matter: rosiglitazone, ramipril, and the prevention of type 2 diabetes.

Nathan DM, Berkwits M.

Ann Intern Med. 2007 Mar 20;146(6):461-3. No abstract available. PMID: 17371892 [PubMed - indexed for MEDLINE]Related articlesFree article

[Influence of diabetes incidence by ramipril and rosiglitazone: DREAM study (diabetes reduction assessment with ramipril and rosiglitazone medication)]

Standl E, Nitschmann S.

Internist (Berl). 2007 Oct;48(10):1173-6. German. No abstract available. PMID: 17846732 [PubMed - indexed for MEDLINE]Related articles

Diabetes prevention: still no effective drugs.

[No authors listed]

Prescrire Int. 2007 Dec;16(92):258.PMID: 18095391 [PubMed - indexed for MEDLINE]Related articles

[The effectiveness in type 2 diabetes prevention: a forced landing to reality]

Costa B.

Med Clin (Barc). 2008 Mar 8;130(8):295-7. Spanish. No abstract available. PMID: 18358121 [PubMed - indexed for MEDLINE]Related articles

[DREAM study: prevention of type 2 diabetes with ramipril and/or rosiglitazone in persons with dysglycaemia but no cardiovascular desease]

Scheen AJ.

Rev Med Liege. 2006 Oct;61(10):728-32. French. PMID: 17209507 [PubMed - indexed for MEDLINE]Related articles

DREAM and ADOPT: rosiglitazone does what it says on the packet.

Bilous R.

Diabet Med. 2007 Feb;24(2):107-9. No abstract available. Erratum in: Diabet Med. 2007 Apr;24(4):449. PMID: 17257270 [PubMed - indexed for MEDLINE]Related articles

DREAM study and its impact on India.

Mohan V.

J Assoc Physicians India. 2006 Oct;54:765-7. No abstract available. PMID: 17214271 [PubMed - indexed for MEDLINE]Related articles

Effect of rosiglitazone/ramipril on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebo-controlled study.

Rahman S, Ismail AA, Ismail SB, Naing NN, Abdul Rahman AR.

Eur J Clin Pharmacol. 2007 Aug;63(8):733-41. Epub 2007 Jun 13.PMID: 17565489 [PubMed - indexed for MEDLINE]Related articles

Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial.

McFarlane SI, Provilus A, Shin JJ.

J Cardiometab Syndr. 2007 Spring;2(2):149-50. No abstract available. PMID: 17684471 [PubMed - indexed for MEDLINE]Related articles

[The DREAM of diabetes prevention]

Ruiz J.

Rev Med Suisse. 2007 Jan 17;3(94):132, 134-6. French. PMID: 17354538 [PubMed - indexed for MEDLINE]Related articles

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

DREAM Trial Investigators, Dagenais GR, Gerstein HC, Holman R, Budaj A, Escalante A, Hedner T, Keltai M, Lonn E, McFarlane S, McQueen M, Teo K, Sheridan P, Bosch J, Pogue J, Yusuf S.

Diabetes Care. 2008 May;31(5):1007-14. Epub 2008 Feb 11.PMID: 18268075 [PubMed - indexed for MEDLINE]Related articlesFree article

[Experiences of the DREAM trial]

Fövényi J.

Orv Hetil. 2006 Dec 31;147(52):2523-6. Review. Hungarian. PMID: 17294577 [PubMed - indexed for MEDLINE]Related articles

Glucose lowering and diabetes prevention: are they the same?

Tuomilehto J, Wareham N.

Lancet. 2006 Oct 7;368(9543):1218-9. No abstract available. PMID: 17027710 [PubMed - indexed for MEDLINE]Related articles

[Therapy of hypertension with ACE inhibitors. One third fewer cases of diabetes]

[No authors listed]

MMW Fortschr Med. 2002 Mar 7;144(10):63. German. No abstract available. PMID: 11928273 [PubMed - indexed for MEDLINE]Related articles

[Three studies in type 2 diabetes: DREAM the wash-out results.]

Roussel R.

Ann Endocrinol (Paris). 2007 Jun;68 Suppl 1:36-8. French. No abstract available. Erratum in: Ann Endocrinol (Paris). 2008 Nov;69(5):459-60. PMID: 17961660 [PubMed - indexed for MEDLINE]Related articles

[Primary prevention of diabetes mellitus by pharmacological intervention]

Noda M.

Nippon Rinsho. 2002 Sep;60 Suppl 9:100-8. Review. Japanese. No abstract available. PMID: 12386980 [PubMed - indexed for MEDLINE]Related articles

HOPE for all people with diabetes? Heart Outcomes Prevention Evaluation.

Marshall SM.

Diabet Med. 2000 Sep;17 Suppl 2:9-10. No abstract available. PMID: 11048826 [PubMed - indexed for MEDLINE]Related articles

[The pharmacological prevention and treatment of diabetes mellitus; significance of 2 recent, large studies for the use of rosiglitazone]

Veneman TF.

Ned Tijdschr Geneeskd. 2007 Mar 3;151(9):514-6. Dutch. PMID: 17373390 [PubMed - indexed for MEDLINE]Related articles

[Parameters of vasomotor function of endothelium and elasticity of arterial wall during therapy with angiotensin converting enzyme inhibitor ramiprilin patients with type 2 diabetes mellitus]

Vikulova OK, Iarek-Martynova IR, Trubitsina NP, Shestakova MV.

Kardiologiia. 2008;48(11):47-52. Russian. No abstract available. PMID: 19076080 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular safety of rosiglitazone.

Krall RL.

Lancet. 2007 Jun 16;369(9578):1995-6. No abstract available. PMID: 17574083 [PubMed - indexed for MEDLINE]Related articles